For analysis of dissected hindlimbs by immunoblotting, hindlimb muscles from Cdo+/+ and Cdo−/− mice at E15.5 (embryonic day 15.5) embryos and P1 (postnatal day 1), P3, and P5 mice were pulverized and solubilized with lysis buffer. Lysates were then analyzed by immunoblotting as described above.
Thomsen-Friedenreich antibodies
These antibodies play a key role in immune surveillance and can be used as biomarkers for cancer detection and monitoring.
PubCompare.ai's AI-driven protocol comparison tool helps researchers optimise their Thomsen-Friedenreich antibody research by identifying the most reproducible protocols from literature, preprints, and patents, providing data-driven insights to enhance reproducibility and accelerate discovery.
Most cited protocols related to «Thomsen-Friedenreich antibodies»
For analysis of dissected hindlimbs by immunoblotting, hindlimb muscles from Cdo+/+ and Cdo−/− mice at E15.5 (embryonic day 15.5) embryos and P1 (postnatal day 1), P3, and P5 mice were pulverized and solubilized with lysis buffer. Lysates were then analyzed by immunoblotting as described above.
Most recents protocols related to «Thomsen-Friedenreich antibodies»
Example 3
Human T cells are infected with the pseudotyped CD28-CA125-PD1 VSV-G virus. 24 hrs to 48 hrs post viral infection, the T cell culture medium is collected and checked for the presence of proinflammatory cytokines. These results will show that T cells are activated by CD28-CA125-PD1 VSV-G, as evidenced by presence of proinflammatory cytokines such as IFN-β and IL-2 in the cell culture supernatant of CD28-CA125-PD1 VSV-G infected human T cells.
EphA2-overexpressing gastric cancer cells, from KATO3 cell line, are infected with pseudotyped CD28-CA125-PD1 VSV-G or non-pseudotyped CD28-CA125-PD1 VSV virus and the cell proliferation is assessed. These results will show that cell proliferation is significantly reduced in cells KATO3 cells infected with pseudotyped CD28-CA125-PD1 VSV-G compared to KATO3 cells infected with non-pseudotyped CD28-CA125-PD1 VSV virus.
Example 8
GPRC5D targeted 28z CAR18 T cells mediated an anti-myeloma immune response. 1×107 U266 human myeloma cell line cells were injected IV into NSG mice on day 0. On day 4 1×106 GPRC5D targeted or CD19 targeted second generation CAR T cells were injected IV. Imaging on day 11 (day 7 s/p CAR T cell injection) shows that, unlike irrelevant (CD19) targeted CAR T cells; GPRC5D A targeted 28z CAR18 T cells can mediate an anti-tumor response. See
Example 8
Binding of trastuzumab to overexpressed HER2 in HER2 amplified cancer cells results in robust interference of constitutive ligand independent PI3K signaling initiated by the deregulated HER2-HER3 complex (Junttila et al. Cancer Res. 74(19): 5561-5571, 2014). The 1Fab-IgG TDB molecule binds to HER2 in bivalent form. In vitro treatment of SKBR3 cells with incubation with 1Fab-IgG TDB resulted in transient non-durable reduction of pAKT, without detectable effect on HER3 phosphorylation (
Example 9
CT26 cell line was engineered to express GD2 as described above (designated CT26 clone #7 or CT25#7 for short). Either 2×105 of wild type (wt) or GD2 positive CD26 cells were inoculated into the flanks of C57BL/6 mice (syngeneic with CT26). 10 days after tumour challenge, mock-transduced and anti-GD2 CAR transduced syngeneic splenocytes were prepared. Mice were divided into the following 4 cohorts: mice with GD2 expressing CT26 tumours receiving anti-GD2 CAR spleoncytes; GD2 expressing CT26 tumours receiving mock-transduced splenocytes; GD2 negative (wt) CT26 tumours with anti-GD2 CAR splenocytes; and GD2 expressing CT26 tumours receiving no splenocytes. Tumour was measured using a digital caliper in 3 dimension and volume estimated therewith.
Antibodies and flow cytometry reagents used in this study were: CD8-Alexa647 (TIB105), CD11c-Alexa488 (N418), CD11c-Alexa647 (N418), CD21/35-Alexa647 (7G6), CD44-Alexa488 (Pgp1), CD44-Alexa647 (Pgp1), CD45.1-Alexa647 (A20), CD45.2-Alexa488 (104), CD317-Alexa647 (eBio927)—lab grown from hybridoma and fluorophore conjugated; PNA-Alexa647 (Vector labs)—lab conjugated; CD4-BV421 (GK1.5), CD4-PE (GK1.5), CD8a-APC-Cy7 (53-6.7), CD11c-PE-Cy7 (N418), CD11b-APC-Cy7 (M1/70), CD11b-PE (M1/70), CD21/35-PerCP-Cy5.5 (7E9), CD23-PE-Cy7 (B3B4), CD38-PE (90), CD44-APCCy7 (IM7), CD62L-APC-eFluor780 (Mel-14), CD93-PE (AA4.1), CD138-BV605 (281-2), CD138-PE (281-2), I-A/I-E-BV605 (M5/114.15.2), T-bet-PE (4B10), TCRβ-PerCP-Cy5.5 (H57-597), TCRβ-BV421 (H57-597)—Biolegend; CD11b-BUV737 (M1/70), CD19-BUV395 (1D3), CD44-BV605 (1M7), CD73-PE (TY/11.8), CD80-BV421 (16-10A1), CD138-BV605 (281-2), CD273-biotin (TY25), SiglecH-BUV737 (440c), Streptavidin-BUV737—Becton Dickinson; CD45.1-APC-eFluor780 (A20), Ki67-FITC (SolA15), BrdU-Alexa647 (Mobu1)—eBiosciences/Invitrogen. All antibodies were titrated prior to use.
Top products related to «Thomsen-Friedenreich antibodies»
More about "Thomsen-Friedenreich antibodies"
These antibodies play a crucial role in immune surveillance and can be used as biomarkers for cancer detection and monitoring.
TF antibodies are of great interest in cancer research as they can bind to the TF antigen, which is overexpressed on the surface of many cancer cells.
The TF antigen is a disaccharide (Galβ1-3GalNAc) that is typically hidden by larger glycan structures in healthy cells but becomes exposed on the surface of tumor cells.
The detection and study of TF antibodies often involve techniques like DAPI staining, flow cytometry using FACSCalibur or LSRFortessa instruments, and Western blotting with PVDF membranes.
Researchers may also use the Foxp3/Transcription Factor Staining Buffer Set or the Cytofix/Cytoperm kit to permeabilize cells and detect intracellular TF antigens.
Bovine serum albumin (BSA) is commonly used as a blocking agent in these assays.
To optimize their TF antibody research, scientists can utilize PubCompare.ai's AI-driven protocol comparison tool.
This tool helps researchers identify the most reproducible protocols from literature, preprints, and patents, providing data-driven insights to enhance reproducibility and accelerate discovery.
By leveraging the information in this tool, researchers can more effectively study the role of TF antibodies in cancer and develop new diagnostic and therapeutic approaches.
Additionally, the use of ionomycin, a calcium ionophore, can induce the expression of the TF antigen on the cell surface, which can be useful for studying the binding and functionality of TF antibodies.
The Image Lab software can also be employed for the analysis and visualization of TF antibody-related data.